Heart failure & cardiomyopathies

Health-Related Quality of Life Among Transthyretin Amyloid Cardiomyopathy Patients

ESC Heart FailPublished Cross-sectional study

Authors' conclusion

KCCQ scores were lower than previously reported for patients with other heart diseases of non-ATTR CM origin. The HRQoL measures correlated well to NYHA class and NAC disease stage. The prevalence of depression appeared to be low.

Study context

Population
Adults (≥18 years) with symptomatic transthyretin amyloid cardiomyopathy (ATTR CM)
Participants
169 adults
Outcome
HRQoL (KCCQ, EQ-5D-5L index and VAS, Major Depression Inventory)
Methodological detailsnon-interventional, multicentre (12 cardiology clinics in Norway, Sweden, Finland and Denmark)
  • Non-interventional
  • Multicentre (12 cardiology clinics in Norway, Sweden, Finland and Denmark)

Main finding

As reported in the abstract

HRQoL scores
Kansas City Cardiomyopathy Questionnaire (KCCQ) total symptom score, mean ± SD
64.3 ± 23.1
KCCQ overall summary score, mean ± SD
64.8 ± 20.9
KCCQ clinical summary score, mean ± SD
65.1 ± 21.5
EQ-5D-5L total utility score
0.8 ± 0.2
EQ-5D-5L Visual Analog Scale (VAS) score
62.9 ± 20.6
No signs of depression
89%

Observational data: associations, not effects.

Further findings

Health-related quality of life (HRQoL) by ATTR CM type

Higher KCCQ overall summary score (OSS) in ATTRv CM vs ATTRwt CM; EQ-5D-5L utility, VAS and Major Depression Inventory (MDI) similar

HRQoL by randomized clinical trials (RCT) participation

Poorer HRQoL in non-RCT vs RCT participants (lower KCCQ OSS and EQ-5D-5L VAS, higher MDI)

HRQoL by New York Heart Association (NYHA) class and National Amyloidosis Centre (NAC) stage

Correlation of KCCQ, EQ-5D-5L and MDI with NYHA class significant after adjusting for multiple testing
P < 0.05
Poorer HRQoL with higher NYHA class and NAC stage (lower KCCQ and EQ-5D-5L, higher MDI)

Original publication

Health-Related Quality of Life Among Transthyretin Amyloid Cardiomyopathy Patients. ESC Heart Fail. Published 22 March 2023. doi:10.1002/ehf2.14350

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.